Search

Your search keyword '"Bernasconi E"' showing total 79 results

Search Constraints

Start Over You searched for: Author "Bernasconi E" Remove constraint Author: "Bernasconi E" Language undetermined Remove constraint Language: undetermined
79 results on '"Bernasconi E"'

Search Results

1. Using longitudinally sampled viral nucleotide sequences to characterize the drivers of HIV-1 transmission

2. Time to Switch to Second-line Antiretroviral Therapy in Children With Human Immunodeficiency Virus in Europe and Thailand

3. Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study

4. Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study

5. Successful Prevention of Transmission of Integrase Resistance in the Swiss HIV Cohort Study

6. Origin of Minority Drug-Resistant HIV-1 Variants in Primary HIV-1 Infection

7. The microbiome in respiratory medicine: current challenges and future perspectives

8. Decreasing mortality and changing patterns of causes of death in the Swiss HIV Cohort Study

10. Combination antiretroviral therapy and duration of pregnancy

11. Phylogenetic Approach Reveals That Virus Genotype Largely Determines HIV Set-Point Viral Load

12. Circulating microRNAs in Sera Correlate with Soluble Biomarkers of Immune Activation but Do Not Predict Mortality in ART Treated Individuals with HIV-1 Infection: A Case Control Study

13. Low-frequency drug-resistant HIV-1 and risk of virological failure to first-line NNRTI-based ART: a multicohort European case–control study using centralized ultrasensitive 454 pyrosequencing

14. Incident Hepatitis C Virus Infections in the Swiss HIV Cohort Study: Changes in Treatment Uptake and Outcomes Between 1991 and 2013

15. Characteristics, Determinants, and Clinical Relevance of CD4 T Cell Recovery to <500 Cells/ L in HIV Type 1--Infected Individuals Receiving Potent Antiretroviral Therapy

16. The interplay between host genetic variation, viral replication and microbial translocation in untreated HIV-infected individuals

17. Missed opportunities among HIV-positive women to control viral replication during pregnancy and to have a vaginal delivery

19. Importance of baseline prognostic factors with increasing time since initiation of highly active antiretroviral therapy: collaborative analysis of cohorts of HIV-1-infected patients

20. Reducing tuberculosis incidence by tuberculin skin testing, preventive treatment, and antiretroviral therapy in an area of low tuberculosis transmission

21. Gilbert syndrome and the development of antiretroviral therapy-associated hyperbilirubinemia

23. Modeling the influence of APOC3, APOE, and TNF polymorphisms on the risk of antiretroviral therapy-associated lipid disorders

24. Combination antiretroviral therapy and duration of pregnancy

25. Amphetamine-induced disruption of latent inhibition is not reinforcer-mediated

26. Amphetamine-induced disruption of latent inhibition depends on the nature of the stimulus

29. High number of potential transmitters revealed in a population-based systematic hepatitis C Virus RNA screening among human immunodeficiency virus-infected men who have sex with men

30. Tenofovir use is associated with a reduction in calculated glomerular filtration rates in the Swiss HIV Cohort Study

32. Prevalence of adverse events associated with potent antiretroviral treatment: Swiss HIV Cohort Study

33. Incidence of tuberculosis among HIV-infected patients receiving highly active antiretroviral therapy in Europe and North America

35. Adverse events to antiretrovirals in the Swiss HIV Cohort Study: Effect on mortality and treatment modification

36. Coping with an HIV infection: A multicenter qualitative survey on HIV positive adolescents' perceptions of their disease, therapeutic adherence and treatment

37. Parents living with HIV in a high-income country: Do patients need specific support?

39. CD4+ T-cell count increase in HIV-1-infected patients with suppressed viral load within 1 year after start of antiretroviral therapy

45. Role of retroviral restriction factors in the interferon- -mediated suppression of HIV-1 in vivo

46. Development of an advanced SiPM camera for the Large Size Telescope of the Cherenkov Telescope Array Observatory

48. European recommendations for post-exposure prophylaxis of HIV-infection in health care workers - Croatian guidelines,Europske preporuke za postekspozicijsku profilaksu HIV-infekcije u zdravstvenih djelatnika - Hrvatske smjernice

49. Estimating the net contribution of IL28B variation to spontaneous hepatitis C virus clearance

Catalog

Books, media, physical & digital resources